JP2011207901A5 - - Google Patents

Download PDF

Info

Publication number
JP2011207901A5
JP2011207901A5 JP2011121052A JP2011121052A JP2011207901A5 JP 2011207901 A5 JP2011207901 A5 JP 2011207901A5 JP 2011121052 A JP2011121052 A JP 2011121052A JP 2011121052 A JP2011121052 A JP 2011121052A JP 2011207901 A5 JP2011207901 A5 JP 2011207901A5
Authority
JP
Japan
Prior art keywords
compound
compound according
emission tomography
general structure
following general
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011121052A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011207901A (ja
JP5341136B2 (ja
Filing date
Publication date
Priority claimed from US08/554,906 external-priority patent/US5808146A/en
Application filed filed Critical
Publication of JP2011207901A publication Critical patent/JP2011207901A/ja
Publication of JP2011207901A5 publication Critical patent/JP2011207901A5/ja
Application granted granted Critical
Publication of JP5341136B2 publication Critical patent/JP5341136B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2011121052A 1995-11-09 2011-05-30 腫瘍画像化のためのアミノ酸アナログ Expired - Lifetime JP5341136B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/554,906 US5808146A (en) 1995-11-09 1995-11-09 Amino acid analogs for tumor imaging
US08/554,906 1995-11-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007120359A Division JP2007246535A (ja) 1995-11-09 2007-04-27 腫瘍画像化のためのアミノ酸アナログ

Publications (3)

Publication Number Publication Date
JP2011207901A JP2011207901A (ja) 2011-10-20
JP2011207901A5 true JP2011207901A5 (enExample) 2012-07-19
JP5341136B2 JP5341136B2 (ja) 2013-11-13

Family

ID=24215200

Family Applications (3)

Application Number Title Priority Date Filing Date
JP51841097A Expired - Lifetime JP3992736B2 (ja) 1995-11-09 1996-11-08 腫瘍画像化のためのアミノ酸アナログ
JP2007120359A Withdrawn JP2007246535A (ja) 1995-11-09 2007-04-27 腫瘍画像化のためのアミノ酸アナログ
JP2011121052A Expired - Lifetime JP5341136B2 (ja) 1995-11-09 2011-05-30 腫瘍画像化のためのアミノ酸アナログ

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP51841097A Expired - Lifetime JP3992736B2 (ja) 1995-11-09 1996-11-08 腫瘍画像化のためのアミノ酸アナログ
JP2007120359A Withdrawn JP2007246535A (ja) 1995-11-09 2007-04-27 腫瘍画像化のためのアミノ酸アナログ

Country Status (6)

Country Link
US (2) US5808146A (enExample)
EP (1) EP0862464B1 (enExample)
JP (3) JP3992736B2 (enExample)
AU (1) AU720738B2 (enExample)
CA (1) CA2237218C (enExample)
WO (1) WO1997017092A1 (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9610967D0 (en) 1996-05-24 1996-07-31 Cambridge Antibody Tech Specific binding members,materials and methods
WO1998030535A1 (en) * 1997-01-08 1998-07-16 Cockbain Julian Amino acid compounds
US20030045681A1 (en) * 1998-05-11 2003-03-06 Anthony J. Zelano Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis
US20030176663A1 (en) * 1998-05-11 2003-09-18 Eidgenossische Technische Hochscule Specific binding molecules for scintigraphy
CA2400622A1 (en) * 2000-02-24 2001-08-30 Eidgenossische Technische Hochschule Zurich Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis
DE10032587A1 (de) 2000-07-05 2002-01-17 Bayer Ag 4-Alkoxy-cyclohexan-1-amino-carbonsäureester und Verfahren zu ihrer Herstellung
EP1381629B1 (de) * 2000-09-07 2008-09-10 Bayer Schering Pharma Aktiengesellschaft REZEPTOR DER EDb-FIBRONEKTIN-DOMÄNE (II)
DE10213051B4 (de) * 2002-03-23 2013-03-07 Grünenthal GmbH Substituierte 4-Aminocyclohexanole
CN101041674A (zh) * 2002-04-30 2007-09-26 埃默里大学 肿瘤成像化合物
DE10239479A1 (de) 2002-08-28 2004-03-04 Bayer Cropscience Ag Substituierte spirocyclische Ketoenole
GB0220619D0 (en) * 2002-09-05 2002-10-16 Blower Philip J Metal binding precursors for the synthesis of peptide-metal conjugates
WO2004044227A2 (en) 2002-11-07 2004-05-27 Board Of Regents, The University Of Texas System Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging
GB0229695D0 (en) * 2002-12-20 2003-01-29 Amersham Plc Solid-phase preparation of 18F-labelled amino acids
WO2005009928A2 (en) * 2003-07-24 2005-02-03 The Queen's Medical Center Preparation and use of alkylating agents
JP4989467B2 (ja) * 2005-05-23 2012-08-01 日本メジフィジックス株式会社 新規有機化合物及び該化合物を利用した放射性ハロゲン標識有機化合物の製造方法
EP1893244A4 (en) * 2005-06-23 2009-06-24 Univ Emory AGENTS FOR IMAGING
CA2612187C (en) * 2005-06-23 2013-05-07 Emory University Stereoselective synthesis of amino acid analogs for tumor imaging
KR101608755B1 (ko) 2005-11-29 2016-04-04 니혼 메디피직스 가부시키가이샤 방사성 할로겐 표식 유기 화합물의 전구체 화합물
ES2380372T3 (es) 2006-05-11 2012-05-11 Nihon Medi-Physics Co., Ltd. Procedimiento para la producción de compuesto orgánico marcado con flúor radioactivo
US7884340B2 (en) * 2006-05-26 2011-02-08 Advanced Biomarker Technologies, Llc Low-volume biomarker generator
US7476883B2 (en) * 2006-05-26 2009-01-13 Advanced Biomarker Technologies, Llc Biomarker generator system
EP2080526A4 (en) * 2006-11-09 2012-11-07 Nihon Mediphysics Co Ltd RADIOACTIVE DIAGNOSTIC IMAGING DAY
EP2128130B1 (en) 2006-12-27 2018-10-10 Nihon Medi-Physics Co., Ltd. Process for production of precursor compound for radioactive halogen-labeled organic compound
JP5258583B2 (ja) * 2007-02-13 2013-08-07 日本メジフィジックス株式会社 放射性画像診断剤の製造方法
US8258313B2 (en) * 2007-07-19 2012-09-04 Tokuyama Corporation Compound having hydantoin ring and method of producing the same
JP5732198B2 (ja) 2007-12-19 2015-06-10 日本メジフィジックス株式会社 放射性フッ素標識有機化合物の製造方法
US8253725B2 (en) * 2007-12-28 2012-08-28 St. Jude Medical, Atrial Fibrillation Division, Inc. Method and system for generating surface models of geometric structures
US8246752B2 (en) 2008-01-25 2012-08-21 Clear Catheter Systems, Inc. Methods and devices to clear obstructions from medical tubes
CA2722344A1 (en) 2008-04-14 2009-10-22 Emory University Imaging agents
US8293207B2 (en) * 2009-09-18 2012-10-23 Valery Zavarzin Radiometal-labeled amino acid analogs, imaging and therapeutic agents incorporating the same, and methods using the same
EP2392568A1 (en) 2010-06-04 2011-12-07 Bayer Pharma Aktiengesellschaft Heterocyclic amino acids for prostate cancer imaging
US20130217908A1 (en) 2010-10-28 2013-08-22 Ge Healthcare Limited Stabilisation of radiopharmaceutical precursors
GB201021530D0 (en) * 2010-12-20 2011-02-02 Ge Healthcare Ltd Purification of precursor compound by crystallisation
US8946124B2 (en) * 2011-02-17 2015-02-03 Bayer Intellectual Property Gmbh Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapy and halogen-substituted spirocyclic ketoenols
CN102757017B (zh) 2011-04-29 2016-04-27 北京大基康明医疗设备有限公司 含氧同位素化合物、制备方法、应用以及组合物
WO2013011115A1 (en) * 2011-07-21 2013-01-24 Ge Healthcare Limited Precursor compounds and methods for making same
GB201214220D0 (en) 2012-08-09 2012-09-19 Ge Healthcare Ltd Radiosynthesis
EP3391898A3 (en) 2013-03-13 2019-02-13 President and Fellows of Harvard College Stapled and stitched polypeptides and uses thereof
GB201305687D0 (en) 2013-03-28 2013-05-15 Ge Healthcare Ltd Radiolabelling process
MX2015017274A (es) 2013-06-14 2016-08-04 Harvard College Moduladores del receptor del polipéptido insulina estabilizados.
US10124079B2 (en) 2015-12-30 2018-11-13 Blue Earth Diagnostics Limited Imaging of metastatic or recurrent cancer
MX2020002435A (es) 2017-09-07 2020-09-22 Fog Pharmaceuticals Inc Agentes que modulan las funciones de beta-catenina y sus métodos.
WO2019165964A1 (zh) * 2018-03-02 2019-09-06 天津谷堆生物医药科技有限公司 环丁烷二羧酸铂配合物、其中间体、其制备方法、药物组合物及用途
JP6864649B2 (ja) 2018-04-19 2021-04-28 信越化学工業株式会社 炭素−炭素不飽和結合が還元されたハロゲン化合物の製造方法
EP4121121A4 (en) * 2020-03-16 2024-09-25 Emory University RADIONUCLIDE TRACERS OF 1-AMINO-3,4-DIFLUOROCYCLOPENTAN-1-CARBOXYLIC ACID, DERIVATIVES AND USES THEREOF
US11980674B2 (en) 2020-06-18 2024-05-14 Blue Earth Diagnostics Limited Imaging of metastatic or recurrent cancer
CN118496070B (zh) * 2024-04-12 2025-10-14 武汉软件工程职业学院(武汉开放大学) 一种3-(苄氧基)-1-环丁酮的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3855208A (en) * 1971-05-24 1974-12-17 Becton Dickinson Co Derivatives of digoxigenin
US4325961A (en) * 1977-06-01 1982-04-20 Merck & Co., Inc. Fluorinated amino acids
US4695588A (en) * 1977-06-01 1987-09-22 Merck & Co., Inc. Fluorinated amino acids
US4743691A (en) * 1977-07-11 1988-05-10 Merrell Dow France Et Cie 2-halomethyl derivatives of 2-amino acids
US4483870A (en) * 1978-07-24 1984-11-20 Merck & Co., Inc. α-Difluoromethyl amino acids and hypertension treating compositions thereof
US4358434A (en) * 1979-12-19 1982-11-09 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds
US4390517A (en) * 1979-12-19 1983-06-28 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds
US4942231A (en) * 1984-05-24 1990-07-17 Mallinckrodt, Inc. Method of preparing a chlorinated, brominated, radio-brominated, iodinated and/or radioiodinated aromatic or heteroaromatic compound
US4760091A (en) * 1985-10-01 1988-07-26 The Dow Chemical Company Method of controlling phytopathogenic fungus
US5227467A (en) * 1987-08-03 1993-07-13 Merck & Co., Inc. Immunosuppressive fluorinated cyclosporin analogs
US5116599A (en) * 1989-07-31 1992-05-26 Johns Hopkins Univ. Perfluoro-t-butyl-containing compounds for use in fluorine-19 nmr and/or mri
CA2026377A1 (en) * 1989-10-03 1991-04-04 John L. Krstenansky Radiolabeled anticoagulant peptides
US5637759A (en) * 1992-07-30 1997-06-10 The Regents Of The University Of California Metal-ligating amino acid derivatives for MRI and for peptide synthesis

Similar Documents

Publication Publication Date Title
JP2011207901A5 (enExample)
JP2011105738A5 (enExample)
JP2013014622A5 (enExample)
JP2011518833A5 (enExample)
JP2009535462A5 (enExample)
JP2009149903A5 (enExample)
JP2009545527A5 (enExample)
JP2012092103A5 (enExample)
JP2012107057A5 (enExample)
JP2016503793A5 (enExample)
JP2013525444A5 (enExample)
JP2013100341A5 (enExample)
JP2013505929A5 (enExample)
JP2012111758A5 (enExample)
JP2013515006A5 (enExample)
JP2013508347A5 (enExample)
JP2013522326A5 (enExample)
JP2010536766A5 (enExample)
EP2217945A4 (en) Single photon emission computed tomography (spect) system for cardiac imaging
JP2014500861A5 (enExample)
JP2012532883A5 (enExample)
PE20120989A1 (es) Sales de disacarina, acido difumarico, acido d-1-hidroxi-2-naftoico y monobenzoico del 2-(4-((2-amino-4-metil-6-(pentilamino) pirimidin-5-il) metil) fenil) acetato de 4-(dimetilamino) butilo
JP2016520672A5 (enExample)
JP2014235432A5 (enExample)
JP2015512943A5 (enExample)